Guest Open Access Plus | Free Content | About | Sign in | New Users: Sign up | Mark List  

Recent Patents on DNA & Gene Sequences

Volume 6 Issue 3
ISSN: 1872-2156
eISSN: 2212-3431

 

   All Titles

  Prometheus: The Supreme Court Redefines the Patentability of Diagnostic Inventions
  pp.193-196 (4) Authors: Andrew Kumamoto, Cora L. Schmid
 
 
      Abstract

The United States Supreme Court recently issued an opinion regarding the patentability of claims directed to diagnostic methods in Mayo Collab. Service v. Prometheus Lab., Inc. In this opinion, the Supreme Court held that correlations between metabolite levels in the human body and either therapeutic efficacy or adverse effects are unpatentable laws of nature. It further found that a patent claim to a method including such a correlation is unpatentable if the remainder of the claim contains only conventional and well-known steps. The Prometheus decision creates uncertainty regarding the scope of patentable subject matter, particularly in the fields of diagnostic and personalized medicine, that will remain until future cases apply this new doctrine.

 
  Keywords: Patents, personalized medicine, patentable, unpatentable, Prometheus, Myriad
  Affiliation: HelixIP LLP, 400 Seaport Court, Suite 105, Redwood City, CA 94063.
 
  Key: New Content Free Content Open Access Plus Subscribed Content

Bentham Science Publishers
www.benthamscience.com

 

  Copyright © 1994 - 2014   Bentham Science Publishers